Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Final phase I/II clinical data presented at European psoriasis meeting for siplizumab

Sep. 25, 2001

Broad development program under way for siplizumab

Sep. 19, 2001

Castor oil component demonstrates both pro- and antiinflammatory properties

Sep. 18, 2001

Allergan's Botox cleared in Canada for treatment of axillary hyperhidrosis

Sep. 13, 2001

Antiscarring PCP inhibitors in the Pfizer pipeline

Sep. 12, 2001

Cellegy seeks MCA approval of Rectogesic for treatment of anal fissures

Sep. 10, 2001

Ortec's OrCel approved for healing donor site wounds in burn victims

Sep. 10, 2001

PH-10 enters phase I study for treatment of actininc keratosis

Aug. 30, 2001

Enbrel shows positive results in phase II clinical study of psoriasis

Aug. 28, 2001

Chrysalis reports positive trends from pilot Chrysalin clinical trial for diabetic ulcers

Aug. 27, 2001

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...